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Abstract Metabolite distribution imaging via imaging mass
spectrometry (IMS) is an increasingly utilized tool in the
field of neurochemistry. As most previous IMS studies
analyzed the relative abundances of larger metabolite spe-
cies, it is important to expand its application to smaller
molecules, such as neurotransmitters. This study aimed to
develop an IMS application to visualize neurotransmitter
distribution in central nervous system tissue sections. Here,
we raise two technical problems that must be resolved to
achieve neurotransmitter imaging: (1) the lower concentra-
tions of bioactive molecules, compared with those of mem-
brane lipids, require higher sensitivity and/or signal-to-noise
(S/N) ratios in signal detection, and (2) the molecular turn-
over of the neurotransmitters is rapid; thus, tissue prepara-
tion procedures should be performed carefully to minimize
postmortem changes. We first evaluated intrinsic sensitivity
and matrix interference using Matrix Assisted Laser Desorp-
tion/Ionization (MALDI) mass spectrometry (MS) to detect
six neurotransmitters and chose acetylcholine (ACh) as a
model for study. Next, we examined both single MS imag-
ing and MS/MS imaging for ACh and found that via an ion
transition from m/z146 to m/z87 in MS/MS imaging, ACh
could be visualized with a high S/N ratio. Furthermore, we
found that in situ freezing method of brain samples im-
proved IMS data quality in terms of the number of effective
pixels and the image contrast (i.e., the sensitivity and dy-
namic range). Therefore, by addressing the aforementioned
problems, we demonstrated the tissue distribution of ACh,
the most suitable molecular specimen for positive ion de-
tection by IMS, to reveal its localization in central nervous
system tissues.
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Imaging mass spectrometry (IMS), a mass spectrometry
(MS)-based molecular imaging technique, is gaining greater
popularity as a means of visualizing the distribution of
molecular ions in tissue sections and cultured cells [1, 2].
The most characteristic feature of this molecular imaging
technique is an MS-based detection principle that has wide
versatility, allowing the analysis of many types of analyte
molecules, particularly using matrix-assisted laser desorp-
tion/ionization (MALDI)-IMS. Consequently, this unique
approach provides a novel opportunity to visualize diverse
types of molecules directly on tissue surfaces, from small
compounds to much heavier biopolymers, which in some
cases can be visualized simultaneously [3–5]. MALDI-IMS
has been successfully applied for the localization imaging of
large structural proteins [6], neuropeptides [7], various types
of membrane lipids [8–11], and energy-related secondary
metabolites [12] in the brains of healthy and diseased mouse
models [13, 14].
This emerging imaging technique was initially developed
as a tool for protein imaging [15–17], and most of the early
reports on MALDI-IMS described it as a protein or peptide
research tool [13, 18, 19]. Conversely, research on detecting
and imaging small metabolite molecules has rapidly been
expanding [11, 20, 21]. Currently, researchers do not have
an established imaging technology for diverse metabolite
species, therefore leading to the emergence of IMS as a tool
for metabolite imaging. Additionally, the ability of IMS to
simultaneously image many types of metabolites is also im-
portant because it can be used to visualize the molecular
“conversion” of upstream metabolites into downstream
metabolites at specific tissue locations in a two-dimensional
manner [21].
Despite the promising capabilities of MALDI-IMS, this
technique still faces several critical problems regarding its
practical use in neurochemical research. One concern is relat-
ed to its quantitative ability. As the matrix compound and
other endogenous isobaric molecules often share nominal
mass with the endogenous metabolites of interest, researchers
cannot simply interpret the obtained ion intensity as being the
analyte concentration. Both peak assignment to specific com-
pounds by mass and careful structural validation by MS/MS
or MS/MS imaging are necessary [22]. The other concern is
insufficient sensitivity for trace amounts of molecules. This is
due to limitations regarding the sample purification process
causing a severe ion suppression effect, whereas molecular
separation techniques such as gas chromatography, liquid
chromatography, and capillary electrophoresis have been tra-
ditionally utilized in MS [23].
For this reason, most IMS studies, including those of the
author’s group, have reported the analyses of abundant
metabolite species, particularly membrane-constituting
lipids. However, it is important to expand the application
of IMS to much smaller amount of molecules, such as
neurotransmitters. The goal of this study was to develop
an IMS application to visualize neurotransmitter distribution
in the central nervous system (CNS). We raise two technical
problems that must be resolved to achieve neurotransmitter
imaging: (1) because there are lower concentrations of the
bioactive molecules than there are of membrane lipids, we
should achieve higher sensitivity and/or selectivity in MS
detection, and (2) the molecular turnover of the neurotrans-
mitters is fast; thus, we also should pay attention to the tissue
preparation procedure to minimize postmortem changes. To
verifytheseproblems,weexaminedthreeanimalorgansusing
fixation techniques, namely, in situ freezing (ISF) [24]a n da
conventional fixation with decapitation at different times, and
we found that brain samples subjected to ISF exhibited im-
proved IMS data quality in terms of the number of effective
pixels and the image contrast, i.e., improved sensitivity and
dynamic range.
Methods
Materials
Acetylcholine (ACh), γ-aminobutyric acid (GABA), gluta-
mate, dopamine, and serotonin were obtained from Sigma-
Aldrich (St. Louis, MO, USA). Norepinephrine was pur-
chased from Wako Pure Chemical Industries Ltd. (Osaka,
Japan). α-Cyano-4-hydroxycinnamic acid (CHCA) and 2,5-
dihydroxybenzoic acid (DHB) were obtained from Bruker
Daltonics (Leipzig, Germany). Male C57BL/6J mice were
purchased from SLC (Hamamatsu, Japan).
Examination of the intrinsic sensitivity using reference
standards
To evaluate the efficiency of ionization and interference by
the matrix, serially diluted (1.0×10
−6 to 1.0 mg/mL) refer-
ence compounds were spotted on a stainless steel plate using
DHB and CHCA as matrices. MS detection was performed
via laser scanning of the spotted areas on the target plate.
Analyte ion intensities and chemical noise from the matrices
were calculated from the region of interest (ROI) drawn on
each sample spot. The x-intercept values were calculated
from the intercepts of the semi-logarithmic graphs that were
plotted with the log values of the compound concentrations
and the signal intensities.
Sample preparation of tissue sections for IMS analyses
All animals received humane care in accordance with the
Japanese Association for Laboratory Animal Science
1852 Y. Sugiura et al.Guidelines, and all of the animal experiments were approved
bytheAnimalExperimentationCommitteeofKansaiMedical
University. For postmortem freezing, mice were deeply anes-
thetized with pentobarbital to relieve suffering. After decapi-
tation, we removed the brains of the animals within 30 s and
the spinal cord within 2 min, and the tissues were frozen in
powder dry ice. Frozen tissues were stored at −80 °C until
sectioning. For ISF, animals were deeply anesthetized with
diethyl ether and the head skin trimmed as described previ-
ously[24].Thetipoftheheadwasdippedintoliquidnitrogen,
with great care taken not to immerse the nose. Frozen brains
were dissected with a surgical knife in a refrigerated box at
−30 °C. For tissue sectioning and matrix coating for IMS
analyses, frozen brains or spinal cords were prepared as 10-
μm cryosections on ITO-coated glass slides (Bruker Dalton-
ics) at −20 °C. The sections on the slide glasses were put in a
compactdesiccatorandthenbroughtout,nottobesurrounded
by frost and not to be degraded by the hydrolytic enzymes.
Then, 50 mg/mL DHB in 70 % methanol and 0.1 % trifluoro-
acetic acid was uniformly sprayed over the samples using a
Procon Boy FWA Platinum 0.2-mm caliber airbrush (Mr.
Hobby, Tokyo, Japan). The samples were subjected to laser
scanning for MALDI-IMS or MS/MS.
Imaging mass spectrometry
We adopted previously described procedures for MALDI-
IMS [20, 25],withsomemodifications. Chemical compounds
and tissue sections were analyzed using a MALDI time-of-
flight (TOF)/TOF-type instrument, the Ultraflex II (Bruker
Daltonics), and a linear ion trap MALDI LTQ XL™ mass
spectrometer (Thermo Fisher Scientific, Waltham, MA,
USA). Data were acquired in the positive ion mode using an
external calibration method. Calibration compounds which
are the aforementioned six neurotransmitters were deposited
on the surfaces of the sample support materials to minimize
mass shift. MS data by TOF/TOF instrument Ultraflex in the
MS mode and 100 laser beam shots were delivered to each
data point (Figs. 2 and 3). LTQ XL linear ion trap mass
spectrometer was also used for MS measurement (Fig. 4).
The intervals between data points were 100 μm (Figs. 4, 5, 6,
and 7a, b) and 50 μm (Fig. 7c). MS/MS imaging was per-
formedusinganLTQinstrumentintheMS/MSmode(Figs.5
and 6) and Ultraflex in “LIFT” MS/MS mode (Fig. 7). In the
MS/MS operation, the data acquisition conditions (i.e., the
laser power, collision energy, and number of laser irradia-
tions)wereoptimizedtoobtainproductionmassspectrawith
high signal-to-noise (S/N) ratios for the fragment peaks.
Image reconstruction
We reconstructed the lipid and neurotransmitter images of
interest from the IMS data. Image reconstruction from signals
in the spectra was performed using FlexImaging (Bruker
Daltonics) and ImageQuest (Thermo Fisher Scientific) soft-
ware. As the ionization efficiency could vary depending on
the matrix–analyte co-crystallization conditions and their sub-
limation during measurement [19, 25], the absolute intensities
of the mass spectra were normalized to the same value of total
ion current for the lipid distribution imaging performed by
LTQ instrument (Figs. 4, 5,a n d6), and this normalization did
not apply the normalization to the MS/MS imaging dataset.
Results and discussion
Evaluation of the intrinsic sensitivity of six
neurotransmitters
In CNS tissues, both specialized structures [26–28]a n d
machinery [29, 30] use neurotransmitters to perform effi-
cient intercellular transduction at chemical synapses, and
physiological concentrations of neurotransmitters are much
lower than those of typical membrane lipids; neurotransmit-
ter concentrations in brain extracellular fluid are in the low
nanomolar range [31–34]. On the other hand, lipids make up
half of CNS tissues (by dry weight); therefore, many major
lipids exist in concentrations of micromoles lipid per milli-
gram tissue. As a result, lipids are observed as dominant
peak clusters in brain MALDI-IMS. [10, 35]. In addition to
ion suppression by scan major metabolites, MALDI ioniza-
tion faces some problems (i.e., interference with the matrix
cluster, alterations during sample preparation, and differ-
ences in ionization efficiency). Therefore, optimization of
typical IMS protocols is necessary to enhance the detection
sensitivity for specific compounds—in this case neurotrans-
mitters—in MALDI-IMS. We first evaluated the compound
intrinsic sensitivity of six representative neurotransmitters to
determine priority for the optimization process (i.e., ease in
ionization and detection in the MALDI-IMS experiment),
namely, ACh, GABA, glutamate, dopamine, serotonin, and
norepinephrine (Fig. 1). For this purpose, we prepared aque-
ous sample solutions of the transmitters at six different
concentrations (tenfold serial dilutions). MS measurements
were performed by imaging prepared regions of samples on
thetargetplate,andtheanalyteionintensities andthematrix-
derived chemical noise were calculated from the ROI drawn
on each sample spot. As a result, we found that ACh has the
highest intrinsic sensitivity (Fig. 2). The mass spectra from
blank matrix spots were acquired; the plotted signal intensity
values inFig.2arethedifference values between thesample-
containing and blank m/z signal intensities (Y-axis, arbitrary
units), whereas the X-axis is the analyte concentration on a
log10 scale. Each plotted square represents the obtained ion
intensity at the indicated analyte concentration. We also
presented R
2 values of collinear approximation. Here, the
ACh distribution in CNS tissue sections by MS/MS imaging 1853estimated theoretical limit of detection is expected to be in
proportion to the x-intercept value; therefore, we utilized the
value for the intrinsic sensitivity evaluation. For five neuro-
transmitters, the protonated molecular ions were observed as
the major ions, whereas norepinephrine could not be
detected as the [M+H]
+ ion form (data not shown). In
Fig. 2, among the six examined neurotransmitters, ACh has
the highest x-intercept, i.e., it has the highest intrinsic sensi-
tivity. We also examined the different matrix compounds,
namely, DHB and CHCA. We performed the same experi-
ment using DHB and compared the x-intercept values and
matrix interference levels. Table 1 summarizes the results,
clearly demonstrating that ACh has the highest intrinsic
sensitivity for both CHCA and DHB. Regarding the matrix
compound, DHB yielded an approximately two times higher
x-intercept value inlogscale thandid CHCA, suggesting that
it is a superior matrix for ACh imaging.
MS/MS ion transition improved the S/N ratio for detecting
ACh-derived signals
Furthermore, monitoring ion transition by MS/MS measure-
ment improved the S/N ratio of the ACh-derived signal by
eliminating matrix interference. Previous studies reported
that collision-induced dissociation of ACh yields a major
fragment ion at m/z87 arising from the loss of trimethyl-
amine [36]. Therefore, we compared the S/N ratio and
sensitivity of ACh-derived signals between single MS meas-
urements (ion at m/z146) and MS/MS measurements (ion at
m/z146>87). Figure 3a shows the results of 1 nM ACh
standard measurements by MS/MS (left) and single MS
measurements (right). For both measurements, the spectra
obtained from the sample-containing spots (red) exhibited
clear ACh-derived signals, whereas those from blank DHB
spots (blue) only exhibited matrix-derived background
peaks. In particular, in the single MS measurement, a
DHB-derived peak observed at m/z146 interfered with the
detection of ACh in the MS mode. Conversely, there was no
observable matrix interference at m/z87 in the product ion
spectrum of m/z146. As expected, this advantage offered an
excellent S/N ratio that is superior to that of the single MS
detection, even for the measurement of a trace sample con-
centration. Figure 3b presents a bar chart showing the S/N
ratio calculated by dividing the signal intensity at m/z146>
87 (MS/MS) and m/z146 (MS) by the corresponding back-
ground peak intensity obtained from the blank spots. These
MS/MS measurements provided an S/N ratio exceeding 100
for the ion transition signal even at a sample concentration
of 1 nM, owing to the low background peak intensity. We
also note that the absolute intensity of m/z146>87 was not
drastically improved, and therefore, the lower detection
limit of ACh was almost equal to that of the single MS
measurement (Fig. 3b, inset).
Fig. 1 Structure and molecular weights of the six neurotransmitters
assessed in this study
Fig. 2 ACh has the highest intrinsic sensitivity among the six assessed
neurotransmitters in MALDI-MS. Shown are the intrinsic sensitivity
evaluation results of the six neurotransmitters using MALDI-MS with
the use of α-cyano-4-hydroxycinnamic acid. The plotted signal inten-
sity values are the difference values between the sample-containing
and blank m/z signal intensities (Y-axis, arbitrary units), whereas the X-
axis is the analyte concentration on a log10 scale. The R
2 values of each
collinear approximation are also shown. The values of the x-intercept
shown in Table 1 represent the detection sensitivity of MALDI-IMS for
the six neurotransmitters
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Having demonstrated that ACh has the highest intrinsic
sensitivity among the analyzed major neurotransmitters,
we proceeded to perform imaging experiments of the distri-
bution of ACh using MALDI-IMS. Here, we utilized mouse
spinal cord sections as a first examination sample because
the distribution pattern of the cholinergic neuron in the
spinal cord is simple and well described [37]. The white
matter outside the spinal cord is composed of nerve fibers,
whereas the inside gray matter mainly consists of neuronal
cell bodies. Therefore, we could easily evaluate the appro-
priateness of the obtained imaging results by comparing the
ion images and anatomical features of the same section. The
initial experiment was performed using single-stage MS
imaging (Fig. 4). However, as can be seen in panel (a), we
failed to detect an isolated signal peak for ACh at m/z146
due to a rather intense peak at m/z141, the foot of which
covered the mass range containing the ACh signal at m/z
146. The existence of this interference peak resulted in a
non-tissue-specific ion distribution at m/z146, suggesting
that this peak did not represent ACh localization (Fig. 4d).
Conversely, peak clusters derived from phospholipids
were clearly observed at a mass range of 700<m/z<900 in
the same section, and their characteristic distribution pat-
terns were useful for understanding the anatomical features
of the tissue sections. For example, because the glycolipid
galactosylceramide counts myelin sheaths as one of its
major lipid components, the ion at m/z850 derived from
galactosylceramide was highly localized in the white matter
region of the spinal cord. In addition, a phosphatidylcholine
(PC) molecular species observed at m/z772 [10, 38], PC
(diacyl-16:0/16:0, K
+ adduct), was localized in the gray
matter region at m/z772, especially in the dorsal spinal horn.
Tandem MS imaging of ACh in mouse spinal cord sections
We further proceeded to MS/MS imaging selection of ions
at m/z146 as a precursor; this method was in turn revealed to
produce high S/N ratios (Fig. 5). In these experiments, we
detected a product ion peak at m/z87, the characteristic and
most intense fragment ion of the ACh molecule [39] which
was derived from the neutral loss of the trimethylamine
group (NL59) from the intact ion (panel a). Figure 3b shows
Table 1 Summary of the detection sensitivity of MALDI-IMS for the
six neurotransmitters using DHB and CHCA as matrices
DHB CHCA
x-intercept
(nM)
Matrix
interference
x-intercept
(μM)
Matrix
interference
Acetylcholine 0.250 + 0.350 +
Serotonin 1.032 ++ 1.000 −
Dopamine 18.70 ++ 8.110 −
GABA 87.24 − 6.865 −
Glutamate 1934 − 73.40 +
Norepinephrine N.D. − N.D. −
Fig. 3 MS/MS ion transition from m/z146>87 improved the S/N ratio
for detecting the ACh-derived signals. a Detection of 1 nM ACh by
MS/MS measurement via an ion transition from m/z146 to 87 (left) and
by a single MS measurement at m/z146 (right). For both, although the
spectra obtained from the sample-containing spots (red) displayed clear
ACh-derived signals, those from blank DHB spots (blue)o n l y
exhibited matrix-derived background peaks; however, in the single
MS measurement, a DHB-derived peak observed around m/z146 in-
terfered with the detection of ACh in the MS mode. Both measure-
ments were repeated for approx. 15 shots, and the obtained spectra
were merged. b Bar chart presenting the S/N ratios calculated by
dividing the signal intensity at m/z146>87 (MS/MS) and m/z146
(MS) by the corresponding background peak intensity obtained from
blank spots. Inset shows the peak intensity plot at m/z146>87 (Y-axis)
along with the dilution series of the ACh standard sample (X-axis).
Datawere acquiredbythe TOF/TOFinstrumentintheMSorLIFTmode
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tion from m/z146 to m/z87), revealing that it is clearly
localized in specific regions of the spinal cord section. We
obtained the lipid signals on the same tissue section which
was used for ACh imaging. The merged image containing
the ion image at m/z772 (Fig. 5c) reveals the intense local-
ization of ACh in the region containing rich motor neurons
in the anterior horn [40, 41], and the overall distribution
pattern was found mainly in the gray matter region.
We noticed high-intensity ACh signals in both the ven-
tral and dorsal horns (Fig. 5c). ACh is an important mod-
ulator of motor and sensory processing, especially at the
spinal level, at which point pain-related nociceptive stimuli
enter the CNS, which integrates the stimuli and relays
them to the brain. There are large cholinergic motor neu-
rons in the spinal anterior horn [40]; thus, it is reasonable
that ACh was abundantly detected in ACh-producing cells
containing choline acetyltransferase (ChAT), the ACh-
synthesizing enzyme [42] .T h es o u r c eo fA C hi nt h e
sensory spinal cord has not been clearly established; how-
ever, the presence of a dense plexus of cholinergic fibers
has been reported in the spinal lamina II [43] and III [44]
with the use of anti-ChAT immunolabeling. In addition to
immunohistochemical findings, exogenous ChAT was
found in the ventral and dorsal horns in ChAT promoter-
driven EGFP-expressing mice [45].
Fig. 4 Single-stage mass spectrometry imaging was not useful for
ACh distribution imaging in the mouse spinal cord section. a Averaged
mass spectrum of all spectra obtained by imaging mass spectrometry of
the spinal cord section. The expanded spectrum (inset) shows that the
intense ion peak at m/z141 hid the mass window for the ACh-derived
ion peak that could be observed at m/z146. b–d Reconstructed ion
intensity maps for ions at m/z850 that were derived from galactosyl-
ceramide (GalCer)( b) and ions at m/z772 derived from the phospha-
tidylcholine PC (diacyl-16:0/16:0)( c). In addition, an ion image at m/z
146 was visualized (d), although merging of that image with GalCer (e)
reveals that this ion was distributed both inside and outside the tissue
sections, suggesting that it contained matrix-derived chemical noise.
Data were acquired by the LTQ instrument with single MS
measurements
Fig. 5 Tandem IMS was useful for determining the distribution of
ACh in mouse spinal cord sections. a The averaged product mass
spectrum of all spectra obtained by IMS of spinal cord sections. The
expanded spectrum (inset) shows that the detection of the ACh-derived
product ion at m/z87 was derived from the neutral loss of the trimethyl-
amine group (NL59) from the intact ion (see the presented molecular
structure). b Reconstructed ion intensity maps for the ion transition from
m/z146 tom/z87(tandem MSsignatureofACh)anditsmergedimageon
the galactosylceramide ion distribution map. c ACh was localized in the
region containing cholinergic motor neurons (arrowheads). Data were
acquired by the LTQ instrument in the MS/MS mode
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whereas conventional methods such as immunohistochem-
istry indirectly described the localization of ACh sites of
action with its receptors, transporters, and synthetic or cat-
abolic enzymes. ISH data of the mouse spinal cord from the
Allen Brain Atlas (http://www.brain-map.org/) demonstrate
that the distribution of IMS images is reasonable compared
with the localization of mRNA for ACh-related molecules
such as ChAT, acetylcholinesterase (AChE), nicotinic recep-
tor (nAChR), muscarinic receptor (mAChR), vesicular ace-
tylcholine transporter (VAChT), and choline transporter
(ChT). Many previous results matching our IMS data also
match those of ISH and/or immunohistochemistry for ACh-
related molecules including ChAT [42, 44, 46], AChE [47],
nAChR [48], and VAChT [46, 49, 50]. Through its action on
spinal cholinergic receptors, endogenous ACh participates
not only in motor action but also in the setting of nocicep-
tive thresholds and in the effect of clinically relevant anal-
gesics; thus, the direct detection of ACh in the spinal cord
will be useful for assessments such as evaluations of thera-
peutic strategies.
Distribution imaging of ACh in mouse sagittal brain
sections
Having demonstrated that ion transition imaging from m/
z146 to m/z87 is an effective IMS protocol for determin-
ing the distribution of ACh in spinal cord sections, we
applied the technique to study sagittal mouse brain sec-
tions. We successfully obtained an ACh distribution im-
age (Fig. 6). The ion transition signal at m/z87 was
abundant in the postsubicular-retrohippocampal region,
superior colliculus, medial fenuculate complex, subpara-
fascicular nucleus, peripeduncular nucleus, lateral dorsal
nucleus of thalamus, reticular nucleus of the thalamus,
fundus of the striatum, olfactory tubercle, reticular part
of the substantia nigra, middle cerebellar peduncle, parvi-
cellular reticular nucleus, facial motor nucleus, medial
vestibular nucleus, parabrachial nucleus, and pontine re-
ticular nucleus (Fig. 6). The distribution of ACh in the
mouse brain reconstructed from IMS data better fits the
patterns of ACh flow areas than that of ACh-producing
areas. For example, the ion transition signal at m/z87 was
abundant in the superior colliculus and nucleus of the
thrums and was observed in the hippocampus and cerebral
cortex in a diffused manner in cholinergic innervation
sites [51]. In contrast, the nuclei of ACh-generating neu-
rons produced a small signal in areas such as the nucleus
basalis of Meynert and the medial septal nucleus. Based
on the Allen Brain Atlas ISH AChE data (Fig. 6e,f )
and previous reports, ACh was mainly distributed at the
neurotransmitter release sites rather than at the nuclei
[52, 53].
The ISF procedure protected endogenous ACh
from postmortem degradation, resulting in improved
MS/MS imaging sensitivity
Earlier studies described that the molecular turnover of
ACh is rapid [54], and therefore, we should pay atten-
tion to the tissue preparation procedure to minimize
postmortem changes. In this context, optimization of
the organ sampling protocol has remained a critical
issue because major degradation of the various metabolites
could occur in tissues even within a second after respiratory
arrest, especially concerning small molecules involved in
signal transduction. As described below, we finally evaluated
the extent of ACh postmortem changes among brain samples
that were subjected to ISF, which ensures adequate perfusion
until the arrival of the freezing front to avoid unnecessary
autolysis, and postmortemfreezing(decapitation beforefreez-
ing). As a result, we found that ISF was the best method for
ACh imaging.
Figure 7a shows the averaged product ion mass
spectrum of m/z146 obtained from the ACh standard
(left) and on the brain tissue (right). The imaging
Fig. 6 Tandem imaging mass spectrometry was useful for ACh distri-
bution imaging in mouse brain sections. a, b Reconstructed ion inten-
sity maps for ions at m/z772 derived from PC (diacyl-16:0/16:0)( a)
and ions at m/z820 derived from PC (diacyl-16:0/20:4)( b). c Recon-
structed ion intensity maps for the ion transition from m/z146 to m/z87
(the tandem mass spectrometry signature of ACh) and its merged
image with the ion distribution map of PC (diacyl-16:0/16:0) (d). e
Scheme of the mouse brain map from the Allen Brain Atlas (http://
www.brain-map.org/). f Image of the intensity map of in situ hybrid-
ization with AChE from the Allen Brain Atlas showing that ACh was
localized in the AChE-abundant region. Data were acquired by the
LTQ instrument in the MS/MS mode
ACh distribution in CNS tissue sections by MS/MS imaging 1857results of the two major ACh-derived ion transition
signatures, m/z146>87 and m/z146>92, exhibited
similar distribution patterns, indicating that the correct
distribution imaging for ACh was achieved. Conversely,
Fig. 7 ISF procedure protected
endogenous ACh from
postmortem degradation,
resulting in improved MS/MS
imaging sensitivity. a Averaged
product ion mass spectrum of
m/z146 obtained from the ACh
standard (left) and on brain
tissue (right). b Representative
ACh and other ion distribution
images visualized by MS/MS
imaging for m/z146, obtained
from three groups of mice
treated with different animal
fixation methods; the tissue
fixation techniques were in situ
freezing (right) and postmortem
freezing with decapitation, in
which brain extraction was
performed within 1 min (center)
and 10 min (left)o f
decapitation. Imaging results of
the two major ACh-derived ion
transition signatures, m/z146>
87 and m/z146>92, exhibited
similar distribution patterns, in-
dicating that the correct distri-
bution map for ACh was
obtained. Conversely, the other
fragment ions (84 and 72)
exhibited a white matter-
specific ion distribution. Obvi-
ously, the ISF sample provided
the most sensitive ACh signal. c
Expanded ACh distribution im-
age of the hippocampus of an
ISF-treated brain (left) and an
optical image of the same brain
section stained with H&E
(right). For reference,
corresponding brain atlas
images are also shown
(bottom). Data were acquired
by the TOF/TOF instrument in
the MS or LIFT mode
1858 Y. Sugiura et al.the other fragment ions exhibited a white matter-specific
ion distribution.
Having observed the ACh-specific ion transitions of
the brain section, distribution maps of the major frag-
ment ions were then reconstructed and evaluated
(Fig. 7b); the quality of these ACh-derived ion images
was assessed among three groups of mice that were
treated with different animal fixation methods, namely,
ISF (right) and postmortem freezing with decapitation in
which brain extraction was performed within 1 min
(center) and 10 min of decapitation (left). As shown
in the figure, the IMS data quality in terms of the
number of effective pixels and the image contrast, i.e.,
sensitivity and dynamic range, was drastically improved
in the ISF brain sample compared with that in the
postmortem freezing-treated group, clearly demonstrat-
ing that the proper sample preparation technique is
necessary for correct ACh imaging. Furthermore, in-
creased sensitivity enables the distribution mapping of
ACh at a higher spatial resolution. Figure 7c shows the
expanded ACh distribution image of the hippocampus
of ISF-treated brains, revealing a unique ACh distribu-
tion pattern even within hippocampal substructures.
Conclusion
Among the neurotransmitters, ACh was most sensitively
detected using the positive ion mode of MALDI-MS.
Based on this fundamental study, we successfully recon-
s t r u c t e dA C hd i s t r i b u t i o ni m a g e si nt h em o u s eb r a i na n d
spinal cord from the scan data obtained from MS/MS
ion transitions. Furthermore, the IMS data quality in
terms of the number of effective pixels and the image
contrast, i.e., the sensitivity and dynamic range, was
d r a s t i c a l l yi m p r o v e di nI S F - t r e a t e db r a i ns a m p l e s ,c l e a r -
ly demonstrating that the ISF sample preparation tech-
nique is necessary for precise ACh imaging.
The localization of ACh obtained in this study coincided
agreeably with the expected localization based on the
known distribution of the ACh-degrading enzyme, especial-
ly in the spinal cord and part of the brain. Therefore, we
conclude that MS/MS-based IMS could be useful for neu-
rotransmitter imaging and can be practically used in the field
of neuroscience.
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